Vascularized islet cell implant for T1D therapy avoids systemic immunosuppression
“Pancreatic islet transplantation efficacy for type 1 diabetes (T1D) management is [MORE]
Smart Hospital
“Technology planned for the new hospital, Houston Methodist’s ninth in Cypress [TX], includes artificial intelligence systems for predictive analytics, [MORE]
Iron Oxide Core for tPA
When the USFDA first approved recombinant tissue plasminogen activator (aka, “clot buster”) in 1996, it came [MORE]